BioPharma Credit PLC Total Voting Rights (6047O)

TIDMBPCR

RNS Number : 6047O

BioPharma Credit PLC

01 February 2023

BioPharma Credit plc

(the "Company")

TOTAL VOTING RIGHTS

In conformity with the Disclosure Guidance and Transparency Rules, the Company notifies the market that the issued share capital and voting rights of the Company, as at 31 January 2023, were as follows:

 
 Class of         Total number    Number       Total number    Number of          Total number 
  share            of shares in    of voting    of voting       shares held        of shares 
                   circulation     rights       rights of       in treasury        in issue 
                                   attached     shares in       (carrying 
                                   to each      circulation     no voting 
                                   share                        rights attached 
                                                                until issued) 
 Ordinary 
  $0.01 shares    1,318,654,886   1            1,318,654,886   55,277,181         1,373,932,067 
                 --------------  -----------  --------------  -----------------  -------------- 
 

The above total voting rights figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in BioPharma Credit PLC under the FCA's Disclosure Guidance and Transparency Rules.

1 February 2023

LEI: 213800AV55PYXAS7SY24

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TVREAFAFEFPDEFA

(END) Dow Jones Newswires

February 01, 2023 09:00 ET (14:00 GMT)